Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

Registrieren

LEXXW Lexaria Bioscience Corporation

0,75

0,14 (22,95%)

10 Jan 2025 - Geschlossen

Verzögert um 15 Minuten

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

Lexaria Bioscience (NASDAQ:LEXXW)
Historical Stock Chart
Von Dez 2024 bis Jan 2025

Click Here for more Lexaria Bioscience Charts.

Lexaria Bioscience (NASDAQ:LEXXW)
Historical Stock Chart
Von Jan 2024 bis Jan 2025

Click Here for more Lexaria Bioscience Charts.

News Lexaria Bioscience Corporation

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Freitag 10 Januar 2025 (6 Stunden vor) • Edgar (US Regulatory)

Form S-8 - Securities to be offered to employees in employee benefit plans
Montag 6 Januar 2025 (4 Tage vor) • Edgar (US Regulatory)

Form 8-K - Current report
Freitag 3 Januar 2025 (1 Woche vor) • Edgar (US Regulatory)

Form 8-K - Current report
Mittwoch 18 Dezember 2024 (3 Wochen vor) • Edgar (US Regulatory)

Form EFFECT - Notice of Effectiveness
Mittwoch 18 Dezember 2024 (3 Wochen vor) • Edgar (US Regulatory)

Form POS AM - Post-Effective amendments for registration statement
Montag 16 Dezember 2024 (4 Wochen vor) • Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]
Donnerstag 5 Dezember 2024 (1 Monat vor) • Edgar (US Regulatory)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Dienstag 26 November 2024 (1 Monat vor) • Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Donnerstag 14 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Freitag 18 Oktober 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Mittwoch 16 Oktober 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Mittwoch 2 Oktober 2024 (3 Monate vor) • Edgar (US Regulatory)

Weitere Lexaria Bioscience Corporation News-Artikel

JP Morgan Chase

Deutsche Lufthansa

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen